recombinant human alpha 1-antitrypsin (AiroMedica)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant human alpha 1-antitrypsin (AiroMedica)
Drug Alias NamerhAAT (AiroMedica)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSerine protease inhibitorsAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinaseSerine protease
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAiroMedica LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAiroMedica LLC
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A